IPO

By Jonah Comstock June 5, 2019
Peloton, the connected fitness company offering home exercise bikes and treadmills with built-in virtual classes, has announced its intention to IPO by filing a confidential draft statement of its S-1 to the SEC. The company is not disclosing the number of shares they plan to offer or their price range. For those that count Peloton as a digital health company, it constitutes one of the most...
By Jonah Comstock March 7, 2019
It's been a while since the digital health space has seen an IPO. But that's about to change, according to The Wall Street Journal, which reports that chronic disease management startup Livongo Health is planning to go public this year.  According to the Journal, the company has hired Morgan Stanley, Goldman Sachs and JPMorgan Chase as underwriters, and is looking towards a valuation over $1...
By Dave Muoio October 5, 2017
Digital physical therapy, telehealth, and patient engagement platform Physitrack will seek public listing on alternative stock exchange Nasdaq First North during the first quarter of 2018, cofounder and CEO Henrik Molin told MobiHealthNews this week. The company has not yet set the terms of this IPO, but said in a statement that it plans to use the offering to fund further expansion into new...
By Jonah Comstock February 2, 2017
Ontario-based PointClickCare, which makes a cloud-based EHR platform and other software solutions to advance senior care -- and recently launched a provider-facing app -- has raised $85 million in new funding. Dragoneer Investment Group led the round with participation from existing investor JMI Equity. “The macro demographics of the aging population, combined with a market-wide shift in payment...
By Jonah Comstock September 26, 2016
iRhythm, maker of the wearable-and-wireless-but-not-connected Zio heart rate monitoring system, has filed with the SEC to raise up to $86 million in an initial public offering.  The Zio patch, iRhythm's sole product as of now, is a small wearable sensor, used for multi-day monitoring of arrhythmias in cardiac patients (up to a fortnight). Unlike many participants in that space, however, the...
By Heather Mack September 7, 2016
Burlington, Massachusetts-based Everbridge, which makes an emergency communications platform for many enterprise and government organizations, set the terms of its initial public offering. The IPO is set at 7.5 million shares, offered at between $11 and $13 per share, equating to a midpoint of $90 million, according to the company’s SEC filings. The company was founded in the wake of 9/11, when...
By Jonah Comstock May 9, 2016
NantHealth, the digital health wing of Dr. Patrick Soon-Shiong's NantWorks portfolio of companies, has registered for an initial public offering. The filing was for a $92 million IPO, which seems quite low for a company that regularly secured nine-figure investments, but is likely just a placeholder. NantHealth has raised at least $680 million from investors that include Allscripts, Blackberry,...
By Jonah Comstock January 14, 2016
Senseonics, a Germantown, Maryland-based company working on a longterm implantable continuous glucose monitor, has filed to go public with an IPO that, for now at least, is valued at $51.75 million.  Senseonics singular offering is a pill-sized sensor that is entirely implanted in the user’s upper arm so that it can continuously monitor their glucose levels. The device is meant to last at least...
By Jonah Comstock October 6, 2015
Health Catalyst CEO Dan Burton Utah-based data warehouse company Health Catalyst is frequently mentioned as a candidate for the next digital health IPO, and CEO Dan Burton coyly addressed that chatter from the stage at Health 2.0 in Santa Clara. "Hard to be a fortune teller there, but we’re trying to think of 2016 as our last year as a private company," he said. Part of the reason Health...
By Jonah Comstock August 19, 2015
Adherium Limited, a New Zealand company working on a smart inhaler, has raised $25.6 million ($35 million AU) in an initial public offering on the Australian Securities Exchange, including a $3 million investment from its partner pharma company AstraZeneca, which just last month announced a longterm commercialization agreement with the company. Adherium makes a line of medical devices that...